In Re Avandia Marketing, Sales Practices & Products Liability Litigation

MEMORANDUM OPINION & ORDER

RUFE, District Judge.

This MDL action arises from injuries allegedly suffered by patients who were prescribed Avandia — an FDA-approved diabetes medication. In 2007, the United States Judicial Panel on Multidistrict Litigation transferred thousands of individual cases to this Court for consolidated pretrial proceedings. The cases allege that Avandia (and its sister drugs Avandamet and Avandaryl) cause an increased risk of heart attack, heart failure, and other physical injury, and that manufacturer GlaxoSmithKline (“GSK”) failed to adequately warn of those risks. 1…